UNSPSC 51172018: Piprozolin or piprozoline

This classification denotes a piperidine with the molecular formula C14H22N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7786W0VV8M, chemically known as ethyl 3-ethyl-4-oxo-5-piperidino-.delta.(sup2, .alpha.)-thiazolidineacetate but generally known as piprozolin, which bears US NIH Compound Identifier 28426. European Medicines Agency schedules Piprozolin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09889MIG.

World Health Organization schedules piprozolin in its Anatomical Therapeutic Chemical (ATC) Classification. PIPROZOLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S1C(N2CCCCC2)C(=O)N(C\1=C\C(=O)OCC)CC.

UNSPSC 51172018 Piprozolin or piprozoline is a Commodity code that in state and local procurement practice encompasses chemical reagents and testing supplies used in drug-screening and forensic laboratory operations. The recent solicitation activity under this code reflects demand for specimen collection logistics, immunoassay screening reagents, and confirmation testing supplies (LC/MS/MS or GC/MS methodologies) in offender drug-testing programs operated by county criminal justice agencies. State and local buyers under this code are primarily county community supervision and corrections departments that manage probation and pretrial monitoring workloads. The scope of work extends beyond the chemical reagent itself to bundled testing services — staffing collection sites, maintaining laboratory certifications (SAMHSA, state DPS, or CAP accreditation), operating randomized testing notification systems, and delivering results electronically. Vendors compete on compliance posture, firm qualifications, client references, and per-test pricing across multiple service models (screening only, confirmation after screening, or combined screening with automatic confirmation of positives).

Collin County Community Supervision and Corrections Department in Texas posted RFP 2026-327 in September 2026 for offender specimen collection and drug testing services, with an anticipated award date of August 10, 2026 and a two-year contract term commencing September 1, 2026 with three optional one-year renewals. The contract carries an estimated annual value of $600,000 and encompasses approximately 25,031 tests per year distributed across five-panel and six-panel screens plus ancillary testing at two collection sites in Plano and McKinney operating Monday through Friday plus five Saturdays annually. The RFP permits award to multiple vendors and requires all pricing to be submitted on a per-test basis with freight, delivery, insurance, and staffing included; price redetermination is capped at medical Consumer Price Index increases not exceeding 3.0 percent annually and applies only at September 1 anniversaries. Funding derives from Texas Department of Criminal Justice appropriations subject to annual availability.